We are live on
!
Find out more
PRTG
Post Resch Tallon Group Portfolio holdings
AUM
$145M
1-Year Est. Return
25.19%
This Fund
S&P 500
This Quarter
Est. Return
-2.03%
1 Year Est. Return
+25.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98M
AUM Growth
-$5.92M
(-5.7%)
Cap. Flow
+$211K
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
45.89%
Holding
109
New
3
Increased
30
Reduced
45
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$529K |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$317K |
| 3 |
Codexis
CDXS
|
+$252K |
| 4 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$213K |
| 5 |
iShares Core US REIT ETF
USRT
|
+$208K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$1.47M |
| 2 |
Xylem
XYL
|
+$260K |
| 3 |
Salesforce
CRM
|
+$236K |
| 4 |
TSMC
TSM
|
+$228K |
| 5 |
KKR & Co
KKR
|
+$207K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.4% |
| 2 | Technology | 11.03% |
| 3 | Real Estate | 7.05% |
| 4 | Healthcare | 6.29% |
| 5 | Financials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sharplink Inc
SBET
$1.82B
| $13.8K | 0.01% |
3,555
| – | – |
|
|
ZOM
102
DELISTED
Zomedica Corp.
ZOM
| $8.85K | 0.01% |
150,000
| – | – |
|
103
Chord Energy
CHRD
$8.39B
| – | – |
-1,717
| Closed | -$204K |
|
|
104
Salesforce
CRM
$208B
| – | – |
-714
| Closed | -$236K |
|
105
CALL
Digimarc Corp
DMRC
$113M
| – | – |
-1,300
| Closed | -$20.1K |
|
|
106
KKR & Co
KKR
$89.9B
| – | – |
-1,386
| Closed | -$207K |
|
|
107
TSMC
TSM
$2.17T
| – | – |
-1,130
| Closed | -$228K |
|
|
108
Xylem
XYL
$25.6B
| – | – |
-2,241
| Closed | -$260K |
|
Similar funds
CG
WSA
NFP
SIP
SO
PWAM
JE
GWM
Post Resch Tallon Group's Q1 2025 Portfolio in Review
As of Q1 2025, Post Resch Tallon Group held 109 positions worth $98M, down 5.7% from $104M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Post Resch Tallon Group's Q1 2025 filing shows 3 new, 30 increased, 45 reduced and 7 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,466 shares worth $206K. The largest sale was Paychex, an estimated $1.47M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 61% a quarter earlier, followed by Technology and Real Estate.
- Post Resch Tallon Group's largest Q1 2025 buy was Bristol-Myers Squibb: 3,466 shares worth $206K.
- Post Resch Tallon Group added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $529K increase.
- Post Resch Tallon Group's biggest Q1 2025 reduction was Paychex, cutting an estimated $1.47M.
- Post Resch Tallon Group fully exited Xylem in Q1 2025, selling an estimated $260K.
- Post Resch Tallon Group's ten largest holdings make up 46% of its $98M portfolio in Q1 2025.
- Post Resch Tallon Group opened 3 new positions and closed 7 in Q1 2025.
- Post Resch Tallon Group's portfolio value fell 5.7% quarter-over-quarter to $98M.
Based on Post Resch Tallon Group's 13F filing for Q1 2025, filed 23 Apr 2025.